Corporate news
Grifols signs an agreement with Cumberland Pharmaceuticals to market ibuprofen for intravenous infusion Impulses the International growth strategy of the Hospital Division
+ info
+ info
Grifols contributes to transfusion medicine education with the third edition of the Transfusion Science Educational Course Grifols delivers a number of courses each year to help train and advance the careers of transfusion medicine professionals who in turn ensure the quality and safety of the blood transfusions
+ info
+ info
Grifols introduces the AlphaKit®; QuickScreen, a novel point-of-care screening device to detect alpha1-antitrypsin (AAT) deficiency, a leading cause of genetic emphysema / COPD in adults Details presented at the annual congress of the European Respiratory Society (ERS).
+ info
+ info
Highlights
Manufacturing
We are a solid company with an international dimension.
Corporate Commitment
We contribute to improving people's health and wellbeing by offering safe, high quality products produced using the latest environmentally friendly technology.
Martín Villar Haemostasis Awards
Grifols is holding the fifth edition of the Martin Villar Awards for Research in Haemostasis. + info
